TROV
TrovaGene, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Trovagene, Inc. is a clinical-stage, precision cancer medicine oncology therapeutics company, which engages in the development of drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, lymphomas, and solid tumors. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan on August 4, 1999 and is headquartered in San Diego, CA.
Market Cap: 14.2 Million
Primary Exchange: NASDAQ
Website: http://www.trovagene.com
Shares Outstanding: 11.9 Million
Float: 11.3 Million
Dividend: (%)
Beta: 0.9936879725738479
Sector: Health Services
Industry: Medical/Nursing Services
Ethical Flags
Longest drawdown: 1400 trading days
From: 2015-06-11 To: 2020-05-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|